ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

Funding Opportunities

January 17, 2003

Practice Management Giant US Oncology To Sell Practices Back to Physicians.

October 5, 2001